1-6 of 6
Pamela S. Becker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

Clinical Trials & Observations
Anna B. Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A. Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Siobán B. Keel, Paul C. Hendrie, Bart L. Scott, M. Cristina Ghiuzeli, Elihu H. Estey, Roland B. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4950–4961.
https://doi.org/10.1182/bloodadvances.2023010392
Published: 2023
Journal Articles

Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation

Michelle C. Krutein, Matthew R. Hart, Donovan J. Anderson, Jasmin Jeffery, Andriana G. Kotini, Jin Dai, Sylvia Chien, Michaela DelPriore, Sara Borst, Jean Ann Maguire, Deborah L. French, Paul Gadue, Eirini P. Papapetrou, Siobán B. Keel, Pamela S. Becker, Marshall S. Horwitz
Journal: Blood Advances
Blood Adv (2021) 5 (3): 687–699.
https://doi.org/10.1182/bloodadvances.2020002709
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical Trials & Observations
Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2032–2043.
https://doi.org/10.1182/bloodadvances.2019000757
Published: 2020
Includes: Supplemental data
Journal Articles

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Clinical Trials & Observations
Frances Linzee Mabrey, Kelda M. Gardner, Kathleen Shannon Dorcy, Andrea Perdue, Heather A. Smith, Alicyn M. Davis, Cody Hammer, Donelle Rizzuto, Sunny Jones, Kim Quach, Bart L. Scott, Paul C. Hendrie, Mary-Elizabeth M. Percival, Roland B. Walter, Frederick R. Appelbaum, Elihu H. Estey, Pamela S. Becker
Journal: Blood Advances
Blood Adv (2020) 4 (4): 611–616.
https://doi.org/10.1182/bloodadvances.2019000707
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia

Clinical Trials & Observations
Harry P. Erba, Pamela S. Becker, Paul J. Shami, Michael R. Grunwald, Donna L. Flesher, Min Zhu, Erik Rasmussen, Haby A. Henary, Abraham A. Anderson, Eunice S. Wang
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1939–1949.
https://doi.org/10.1182/bloodadvances.2019030916
Published: 2019
Journal Articles

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

Clinical Trials & Observations
Damian J. Green, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Leona A. Holmberg, Pamela S. Becker, Min Fang, Paul J. Martin, George E. Georges, Michelle E. Bouvier, Rainer Storb, Marco Mielcarek
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2247–2256.
https://doi.org/10.1182/bloodadvances.2017010686
Published: 2017